News Column

Regeneron Names Pfizer Executive As CFO

September 10, 2013

Regeneron has named a Pfizer executive to replace longtime chief financial officer Murray Goldberg, who retires next year.

Robert Landry was senior vice president and treasurer at Pfizer Inc. Regeneron cited his domestic and international pharmaceutical financial expertise.

Goldberg, who has been the CFO at Regeneron Pharmaceuticals Inc. for 18 years, will become senior vice president of administration before his retirement at the end of 2014.

The company, based in Tarrytown, N.Y., develops medicines for eye diseases, colorectal cancer and a rare inflammatory condition.

Shares of Regeneron increased $1.48 to $278.28, in line with a broader market uptick.

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Original Headline: Regeneron appoints new CFO

Source: Copyright 2013 The Associated Press.

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters